News

The muon magnetic field has been a mystery to science for a long time. The reason for this is the discrepancy between the results of experimental measurements of the magnetic field and their theoretical predictions. Now, a scientific team has succeeded in bringing the theoretical predictions and the experimental value closer together. Among others, JARA-CSD Director Prof. Thomas Lippert and the Jülich Supercomputing Centre (JSC), which he heads, played a key role in the investigations.

Read more
JARA | FIT

Several characteristics of graphene make the material interesting for the design and development of spin qubits for future quantum computers. It is therefore not surprising that research on graphene-based quantum dots has been going on for more than a decade. A team of researchers led by JARA-FIT Director Prof. Christoph Stampfer has now made major progresses in the technology for confining and manipulating electrons in bilayer graphene quantum dots bringing the demonstration of graphene-based qubits within reach. The group has already published several papers on this topic in renowned journals.

Read more
JARA | ENERGY

The Committee of the European Ceramic Society (ECERS) unanimously elected JARA-ENERGY member Prof. Olivier Guillon, Director of the Institute for Energy and Climate Research, Materials Synthesis and Manufacturing Processes (IEK-1) at Forschungszentrum Jülich, as this year's Fellow. Guillon was elected at the ECERS meeting on February 17, 2021.

Read more
JARA | ENERGY

RWTH Aachen University awarded the "IntSpire" prize for the first time this year. The Institute of General Mechanics, led by JARA-ENERGY member Professor Bernd Markert, prevailed against 30 other nominees. The prize honors employees, students, chairs, institutes, or institutions of the university that have especially fostered an international culture at RWTH.

Read more
JARA

For more than a year, the Corona virus and its effects have been daily companions of the world population. Various vaccine serums against the virus are now being successfully used, but until now there has been no medication to stop the disease. In the EU project EXSCALATE4CORONAVIRUS, researchers from Forschungszentrum Jülich now presented a prediction of which molecules could inhibit the main protease of SARS CoV 2.

Read more